Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations Terminated Phase 1 Trials for Binimetinib (DB11967)

IndicationStatusPhase
DBCOND0137462 (Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04965818Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant CancerTreatment